qcmsr576 | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/qcmsr576_hasAnnotation_C1537935>
?:creator	<https://research.tib.eu/covid-19/entity/Hien%2C_Doan_Luong%3B_Pham%2C_Brandon_Huy%3B_Nguyen%2C_Quan_Dong>
?:doi	<https://research.tib.eu/covid-19/entity/10.18502/jovr.v15i4.7777>
?:doi	10.18502/jovr.v15i4.7777
?:journal	J_Ophthalmic_Vis_Res
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/0e900344ec7439495f9b576300560441ae34cf6b.json
?:pmc_json_files	document_parses/pmc_json/PMC7591831.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7591831>
?:pmid	<https://research.tib.eu/covid-19/entity/33133433.0>
?:pmid	33133433.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/0e900344ec7439495f9b576300560441ae34cf6b>
?:source	Medline; PMC
?:title	How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-25

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/qcmsr576>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/qcmsr576>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all